This Week in JAMA | GenomeWeb

This Week in JAMA

Premium

In JAMA this week, researchers in the US and Sweden assess cancer risk among patients with myotonic muscular dystrophy, autosomal-dominant multisystem neuromuscular disorder. Previous case reports have suggested that patients with this type of dystrophy, which is characterized by unstable nucleotide repeat expansions, may be at increased risk for malignancies. For this study, the researchers analyzed data from 1,658 MMD patients, and found that 104 developed cancer following their MMD diagnosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.